Introduction
Polyurethanes are widely used in biomedical devices such as heart valves, pacemaker leads, catheters, vascular devices, and surgical dressings because of their excellent mechanical properties and good biocompatibility. 1 The addition of layered silicate nanoparticles to different polyurethanes can form nanocomposites with significantly increased tensile strength and breaking strain. 2, 3 These nanocomposites have the potential to increase the life span of biomedical devices that suffer from wear in vivo. However, all polyurethanes exhibit some degree of biodegradation, which would lead to the release of nanoparticles at the site of implantation. Despite the growing use of layered silicates as drug delivery systems 4, 5 and in medical devices, 2,3 very little is known about how these nanoparticles interact with proteins and cells.
It has been widely reported that the physical properties of a material can change dramatically at the nano-scale. [6] [7] [8] Overt toxicity, for example, generally increases as size decreases. This has been shown for amorphous silica, 9 silver, 10 and metal oxides.
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Tee et al also bind to proteins that can enhance or inhibit cell binding and uptake. The accumulation of many nanoparticles into cells is central to their biodistribution and removal from the body, as well as many of their unwanted side-effects. Macrophage cells are of particular interest as they are a major component of the foreign body reaction 16 and are known to play a role in the clearance of nanoparticles from the body. 17, 18 While there is a number of processes by which cells can internalize nanoparticles, 4, 19, 20 it was recently shown that layered silicate nanoparticles are taken up by human macrophages via scavenger receptor mediated phagocytosis, 21 which was dependent on surface protein binding.
Synthetic fluoromicas are high aspect ratio nanoparticles that can impart important property changes to polyurethanes including increased tensile and tear strength and toughness without a significant increase in hardness or elastic modulus. 22 This suggests that nanocomposites containing fluoromicas may be useful in the manufacture of implanted devices where strength and durability are essential. In the present study, a series of fluoromica nanoparticles with varying platelet sizes were generated from the same base material ME100 [23] [24] [25] [26] [27] by high energy milling and differential centrifugation. These nanoparticles were then tested in human and murine cells to determine if changes in size affected toxicity and/or cell uptake.
Methods
Particle preparation
ME100 (CBC Co. Ltd, Tokyo, Japan) was dispersed in MilliQ water at 33.3 g/L and high-energy milled in a LabStar laboratory agitator bead mill (Netzsch Group, Selb, Germany) loaded with 0.4 L of 0.4 mm 100% zirconium oxide beads. The mill was run at a speed of 1,250 rpm and temperature of 33°C for 4 hours. The milled nanoparticles were initially centrifuged in an Allegra X-15R (Bechman Coulter Inc, Brea, CA, USA) with an SX4750 rotor at 5,250× g to remove most of the large agglomerates, and then separated by differential centrifugation in an Avanti J-25I (Bechman Coulter), with JA-20 rotor at 7,700× g, 17,400× g, 31,000× g and 48,400× g. The pellet from the final centrifugation was resuspended and collected as the smallest nanoparticle fraction.
Determination of particle size and surface charge
The hydrodynamic diameter and zeta-potential of the nanoparticles were estimated by dynamic light scattering and electrophoretic light scattering, respectively (Nanosizer Nano ZS; Malvern Instruments, Malvern, UK). Aqueous dispersions of milled ME100 fractions were ultrasonicated in an ultrasonic bath for 30 minutes before use.
Fourier transform infrared spectroscopy
Fourier transform infrared spectra were recorded using a Nicolet 5700 FT-IR spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) fitted with a diamond attenuated total reflection accessory. Spectra were recorded from a wavenumber of 525 to 4,000 cm -1 .
scanning microscope imaging
The nanoparticle suspension was diluted to 0.02 mg/mL and ultra-sonicated for 30 minutes. A small droplet of suspension was placed on a silicon wafer and dried in a vacuum oven for at least 7 hours at 70°C. The sample was then splutter coated with platinum at 15 mA for 50 seconds (Bal-Tec MED 020; Leica Microsystems, North Ryde, NSW, Australia). Images were obtained using a JSM-7001F Field Emission scanning electron microscope (JEOL, Tokyo, Japan) at different accelerating voltages.
Fluorescent labeling of nanoparticles
The fluoromica nanoparticles were labeled by intercalation of the cyanine dye, YOYO-1 (Thermo Fisher Scientific) as previously described. 21 Briefly, the dye was added at a concentration of 2 pmol/mg of nanoparticles, sonicated (50-60 Hz, for 10 minutes) then incubated at 4°C for 24 hours under subdued lighting. Preliminary studies established the absence of free dye in solution and stability of the intercalated dye over the time of each experiment, as outlined elsewhere. 21 
cell culture
Human acute monocytic leukemia cells (THP-1), human cervical adenocarcinoma epithelial cells (HeLa), and mouse leukemic monocyte macrophage cells (RAW 264.7) were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA) and grown at 37°C in a humidified 5% CO 2 atmosphere. THP-1, HeLa, and RAW cells were cultured in Roswell Park Memorial Institute 1640 (Thermo Fisher Scientific) supplemented with 5% fetal bovine serum (FBS) and antibiotics (50 U/mL penicillin and 50 µg/mL streptomycin).
Differentiation of THP-1 cells into macrophage cells (dTHP-1) was achieved by treating cells with 100 ng/mL phorbol 12-myristate 13-acetate (Sigma-Aldrich Co., St Louis, MO, USA) for 72 hours prior to the start of the experiment. 
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Fluoromica toxicity in macrophages cell attachment. THP-1 cells were grown in suspension, and seeded at 500,000 cells/mL immediately before beginning the experiments. When different serum conditions were required, adhesive cells were seeded and allowed to attach in 5% FBS medium. Immediately prior to starting the experiment, this medium was removed and replaced with either serum free medium, or medium containing different concentrations of FBS.
In vitro toxicity of nanoparticles
Cell viability was assessed by CellTiter 96 ® AQueous One Solution Cell Proliferation Assay (Promega Corporation, Fitchburg, WI, USA) according to manufacturer's instructions. Cells were incubated in complete culture medium with nanoparticles at concentrations from 0-100 µg/mL for 24 hours. Time-dependent toxicity was measured after incubation with nanoparticles at 30 µg/mL for 1, 4, 8, and 24 hours. After the incubation period, the assay solution (20 µL/well) was added directly to the wells and cells were incubated for a further 30 minutes before absorbance at 490 nm was measured in a POLARstar Omega microplate reader (BMG Labtech, Ortenberg, Germany). Cell free controls, used to check interference of the assay by the nanoparticles, were performed for each study.
Membrane leakage assay
Cell membrane leakage was assessed by lactate dehydrogenase (LDH) assay of cell supernatants. Nanoparticles were added to cells at 30 µg/mL and incubated for 4 hours. Plates were then centrifuged at 400× g for 10 minutes, 100 µL of supernatant was removed and placed in a fresh, cell-free 96-well plate. LDH assay buffer (54 mM lactic acid, 0.28 mM phenazine methosulfate, 0.66 mM iodonitrotetrazolium violet and 1.3 mM nicotinamide adenine dinucleotide in Tris buffer) at pH 8.2 was added to the supernatants. Immediately after addition, absorbance at 490 nm was measured, and measurement was repeated every minute for 5 minutes. Cells lysed with 0.1% TritonX-100 were used as positive control.
apoptosis assay
Apoptosis was determined using fluorescently-labeled annexin V. Although apoptotic and necrotic cells normally can be separated using membrane impermeable propidium iodide, preliminary studies indicated binding of propidium iodide to the nanoparticles, which interfered with the assay. Consequently, annexin V staining was only used with cells shown to have intact cell membranes (that is, no LDH release).
Cell staining was performed according to manufacturer's instructions (Dead Cell Apoptosis Kit with Annexin V Alexa Fluor ® 488 and Propidium Iodide; Thermo Fisher Scientific). Briefly, cells were incubated with nanoparticles for 4 hours, then washed with phosphate buffered saline (PBS) and binding buffer. The cells were then resuspended in 100 µL of binding buffer (100,000 cells/mL) and incubated with 5 µL annexin V solution for 15 minutes on ice. Each sample was then diluted with 400 µL of binding buffer and measured by flow cytometry, as described below.
Uptake of nanoparticles into cells
Association of fluorescently labeled nanoparticles with cells was assessed by flow cytometry and confocal microscopy. YOYO-1 labeled nanoparticles were incubated with cells at a concentration of 10 µg/mL for 4 hours. This concentration was chosen as it produced no cytotoxicity within 4 hours. Medium was then removed and the cells were washed twice with 1 mL of PBS. Adherent cells were detached with trypsin and gently aspirated to disaggregate cells. Cells were then transferred to round-bottom vials (BD Biosciences, San Jose, CA, USA) and diluted to a total of 1 mL of PBS. RAW cells were washed, as described above, then gently scraped from the surface of the culture wells, suspended in 1 mL of PBS by gentle aspiration and placed in round-bottom vials.
Polyinosinic acid, when used to block scavenger receptors, was added to cell culture medium at 100 µg/mL, 60 minutes prior to addition of nanoparticles.
Flow cytometry
Samples were analyzed on a BD Biosciences FACSCanto flow cytometer (BD Biosciences, USA), controlled by BD FACSDiva v5.0.3 software (BD). Annexin V-FITC and YOYO-1 labeled nanoparticles were detected at an excitation of 488 nm and an emission at 530 nm with a slit size of 30 nm.
confocal microscopy
Cells were seeded onto sterile glass coverslips placed at the bottom of 12-well plates (2 mL/well) as described above. YOYO-1 labeled nanoparticles were added to the medium at a concentration of 10 µg/mL for 4 hours. After the incubation period, the cells were washed twice with 1 mL of PBS and fixed at room temperature for 30 minutes with 4% paraformaldehyde in cytoskeletal buffer [10 mM KCl, 600 mM sucrose, 4 mM ethylenebis(oxyethylenenitrilo) tetraacetic acid, 2 mM MgCl 2 , 10 mM piperazine-N,N'-bis(2-ethanesulfonic acid)]. Fixed cells were then washed 
One-dimensional gel electrophoresis
Nanoparticles (100 µg/mL) were incubated with 5%, 40% or 80% FBS in PBS at 37°C for 1 hour. After incubation, particles were separated by ultracentrifugation (200,000× g, 60 minutes, 4°C, Hitachi GX series, CS120 GXL; Hitachi Ltd., Tokyo, Japan), and washed in PBS to remove unbound proteins. The nanoparticles were then mixed with 100 µL of sodium dodecyl sulfate (SDS) buffer (2% SDS, 5% β-mercaptoethanol, 10% glycerol, and 62.5 mM Tris-HCl) and heated to 95°C for 5 minutes. These protein samples (40 µL/sample) were separated on a 12% polyacrylamide gel at a constant 200 V for 45 minutes. Gels were stained with SyPRO ruby (Bio-Rad Laboratories, Inc., Hercules, California, USA) at room temperature overnight then washed and imaged in a ChemiDoc XRS system using Quantity One 4.5.0 software (both from Bio-Rad Laboratories Inc., Hercules, CA, USA).
statistical analysis
All results are presented as mean ± standard deviation, unless otherwise stated. Significance was determined at P,0.05 using two-tailed Student's t-test or one-or two-way analysis of variance (ANOVA), as required.
Results
characterization of nanoparticles
Electron micrographs of the different milled fluoromicas are shown in Figure 1A . The unmilled ME100 particles have a high aspect ratio typical of this class of layered silicates. 28 The platelets showed considerable heterogeneity in size and shape. As the particles were milled to smaller sizes, they showed greater uniformity and structure. The smallest particles (F-90) consisted primarily of nanoparticles approximately 100 nm in diameter, but smaller particles were also evident. The hydrodynamic diameters for each of the fractions are shown in Figure 1B , and were 1,000 nm, 600 nm, 250 nm, 220 nm, and 90 nm, respectively. These fractions will be referred to as ME100, F-600, F-250, F-220, and F-90 from largest to smallest. Some of the nanoparticle fractions were not monodispersed. This was particularly evident for the F-90 nanoparticles which showed a second population with a hydrodynamic diameter of approximately 20 nm. Nevertheless, the milling and separation process produced four nanoparticle fractions with distinctly different size profiles.
The zeta potentials of the largest and smallest particles were compared to determine the effect of milling on surface charge ( Figure S1A ). The unmilled particles had a zeta potential of -40±7.2 mV and this increased slightly to -30.5±0.9 mV in the F-90 fraction. Fourier transform infrared spectroscopy was also employed to identify potential changes during milling. The spectra were similar to published data 27 and were not affected by processing ( Figure S1B ).
Nanoparticle toxicity
The cytotoxicity of the different nanoparticles' fractions was determined after 24 hour exposure to concentrations up to 100 µg/mL (Figure 2 ). In the two macrophage lines (dTHP-1 and RAW cells), the larger particles showed a dosedependent decrease in viability, although the murine RAW cells appear to be more sensitive. The IC 50 concentrations for these particles (ME100, F-600, F-250, and F-220) ranged from 8 to 15 µg/mL in the dTHP-1 cells (Figure 2A ) but were less than 10 µg/mL in the RAW cells ( Figure 2B ). The smallest particles (F-90) showed little toxicity in the human dTHP-1 cells and were the least toxic in the RAW cells. For comparison, non-macrophage human HeLa cells were also examined ( Figure 2C ). The viability profiles were similar to those seen in the dTHP-1 cells, although toxicity was considerably less (IC 50 =40-50 µg/mL).
The temporal changes in cell survival for each of the nanoparticles (30 µg/mL) are shown in Figure 3 . For the larger particles, a loss in viability was seen as early as 2 hours following treatment in both macrophage cell lines. Again, little or no cytotoxicity was seen with the F-90 nanoparticles in the dTHP-1 cells. In RAW cells (Figure 3B ), the F-90 nanoparticles caused cell death but at a significantly slower rate than the larger particles. By 24 hours, cell viability was similar for all particles. The difference in time-dependent toxicity for the F-90 nanoparticles suggested that cell death may result from a mechanism different to that with the larger particles.
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cell membrane integrity and apoptosis
To test whether the loss in cell viability at early time points (4 hours) resulted from membrane disruption, the release of LDH into the medium was measured. For both dTHP-1 and RAW cells, LDH release increased with increasing hydrodynamic diameter ( Figure 4A ), although this was more marked in the RAW cells. In the dTHP-1 cells, release was linearly related to size whereas maximal release was seen in the RAW cells for nanoparticles with a mean diameter of 250 nm. This is similar to the decrease in viability at 4 hours shown in Figure 3 . The smallest nanoparticles (F-90) showed no increase in LDH release in either cell line. Consequently, induction of apoptosis by the F-90 particles (30 µg/mL) at 4 hours was determined by annexin V staining. In the dTHP-1 cells, there was no evidence of apoptosis ( Figure 4B ) consistent with the lack of cytotoxicity in this cell line. By contrast, the F-90 nanoparticles significantly increased annexin V staining in the RAW cells indicative of an apoptotic response to these particles.
Nanoparticle uptake
The uptake of the different nanoparticles was determined in dTHP-1 and RAW cells. 
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Tee et al the F-220 and F-90 nanoparticles, which showed slightly less uptake in dTHP-1 cells compared to the larger particles ( Figure 5A, left panel) . Previously, we have shown that layered silicate nanoparticles can be taken up into macrophages via the scavenger receptor. 21 To test this possibility with the fluoromicas, we pretreated cells with polyinosinic acid, a broad inhibitor of scavenger receptors. Figure 5B shows that the degree of inhibition of uptake by polyinosinic acid increased as the mean hydrodynamic diameter decreased, with more than 75% inhibition of the F-90 nanoparticle uptake but less than 10% inhibition of the unmilled ME100 particle uptake. This was consistent for both cell types.
We next examined cell association of the largest and smallest particles by confocal microscopy ( Figure 6 ). There were clear differences for the different particles. The ME100 particles were found mostly associated with the cell membrane with little evidence of internalization. By contrast, the F-90 nanoparticles were almost entirely associated with intracellular vesicles. These observations are consistent with the effects of polyinosinic acid in Figure 5B and suggest that the smaller particles are extensively internalized by both dTHP-1 cells and RAW cells. Moreover, this internalization most likely involves scavenger receptors since it was inhibited by polyinosinic acid.
Binding of protein to nanoparticles
Cell surface recognition of nanoparticles is often dependent on the type of proteins associated with the corona that forms in biological fluids such as plasma. 29 Therefore, we next examined the pattern of serum protein binding to the largest (ME100) and smallest (F-90) particles in the presence of increasing serum concentration (Figure 7) . The total bound protein was similar for both particles. The banding patterns were also similar, although there were significant differences Figure 6 confocal microscopy of dThP-1 and raW cells exposed to Me100 or F-90 nanoparticles (10 µg/ml) for 4 hours. 
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Fluoromica toxicity in macrophages within each particle as the serum concentration increased (Figure 7, arrows) . This indicates that the composition of the protein corona varied between low and high serum concentrations.
effect of serum concentration on nanoparticle uptake and toxicity
Since altering the serum concentration induced changes in the protein corona associated with the different fluoromica nanoparticles, we next asked whether this affected either cell uptake or toxicity in dTHP-1. For both ME100 and F-90 nanoparticles (10 µg/mL), there was no difference in uptake with the different serum concentrations ( Figure 8A ). Similar to the results in Figure 5B , polyinosinic acid did not inhibit the uptake of ME100 at any serum concentration. By contrast, polyinosinic acid significantly decreased the uptake of F-90 nanoparticles in the presence of 5% or 80% serum, but not in the absence of serum ( Figure 8A ). These data indicate that serum proteins were necessary for scavenger receptor recognition by the F-90 particles.
Serum concentration also affected the toxicity of the different fluoromicas. At 5% serum, the ME100 particles (30 µg/mL) induced a rapid decrease in cell viability while the F-90 nanoparticles did not. This was consistent with the data in Figure 3A . At 80% serum, toxicity of ME100 was still evident, but significantly diminished. By contrast, the F-90 nanoparticles showed little or no toxicity in 5% and 80% serum, but decreased cell viability in the absence of serum ( Figure 8B, right panel) .
Discussion
Synthetic fluoromicas are high aspect layered silicates that have been extensively studied as nanofillers in polymeric composites. The nanofiller can enhance the mechanical properties of the composite by direct interaction with the polymer chains. 30, 31 Moreover, these composites have been studied as potential components in medical implants, and as drug delivery systems. 32, 33 Consequently, as part of their safety evaluation, human exposure to fluoromica nanoparticles requires an understanding of their potential biological interactions and adverse effects. Here, we show using a series of synthetic fluoromica nanoparticles formed by high energy milling of the same base product (ME100), that these nanoparticles behave differently to many other nanoparticles when exposed to phagocytic cells.
Size has a clear effect on the uptake and toxicity of the fluoromica nanoparticles in both human and murine macrophages. The larger nanoparticles showed greater toxicity, causing rapid membrane disruption and cell death as early as 4 hours of exposure. Conversely, the smallest (F-90) nanoparticles displayed very little toxicity in dTHP-1 cells and were significantly less toxic than the larger particles in RAW cells. These findings are in contrast to studies of other nano-sized particles where increased toxicity has been associated with a decrease in size. 5, 9, 12, 34, 35 Generally, the higher surface area is cited as the likely cause of increasing toxicity. A major difference between many of the nanoparticles previously studied and the fluoromicas is their aspect ratio. This is the ratio of their diameter to their thickness. Fluoromicas, and most other clays, are very thin platelets with a thickness less than 10 nm. It would be interesting for future studies to address the relationship between aspect ratio, internalization, and cytotoxicity in a series of particles derived from the same material.
A major difference between the different fluoromica particles was the ability of the smallest particles to be internalized by both dTHP-1 and RAW cells by scavenger receptor mediated phagocytosis. The larger particles primarily decorated the cell surface. Phagocytosis was dependent on serum proteins, which is a similar observation to that reported for hectorite, another layered silicate nanoparticle that is internalized by macrophages. 21 In those studies, albumin was shown to unfold revealing a cryptic epitope that was recognized by Class A scavenger receptors. It was not the purpose of the current study to clearly define the internalization process for the fluoromica nanoparticles, and further studies will address the similarities or differences in how macrophages might handle different layered silicate nanoparticles intended for human use.
The fluoromica nanoparticles induced cell death by different mechanisms dependent on their size. The larger particles directly damaged the cell membrane leading to a rapid release of LDH. This was proportional to size in the dTHP-1 cells. RAW cells were significantly more sensitive to the fluoromicas with maximum membrane damage seen with the F-250 particles. While both cell types have common macrophage properties, they differ significantly in their membrane composition. For example, dTHP-1 cells express CAV1 whereas RAW cells do not. 36 In addition, there are higher levels of cholesterol associated with the caveolae in dTHP-1 cells. The disruption of the cell membrane was partially, but not completely, abrogated by the protein corona formed when the nanoparticles were incubated with serum. By contrast, the F-90 nanoparticles showed little cytotoxicity in the human dTHP-1 cells although they induced apoptosis in the murine RAW cells. Several studies have demonstrated an apoptotic response in macrophages following scavenger receptor activation by nanoparticles. [37] [38] [39] For silica nanoparticles, activation of CASP1 was essential for apoptosis 40 while CASP9 appeared to be involved in scavenger receptor mediated apoptosis by multi-walled carbon nanotubes. 41 International Journal of Nanomedicine 2015:10 submit your manuscript | www.dovepress.com
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These results suggest multiple pathways that nanoparticles may use to induce apoptosis in cells such as macrophages.
Conclusion
The cytotoxicity of synthetic fluoromicas is dependent on the nanoparticle platelet size but in a manner that is opposite to many other types of nanomaterials. These findings provide initial evidence that smaller fluoromica nanoparticles may be safer for use in humans but their propensity to recognize macrophage scavenger receptors also suggests that they are likely to target the reticulo-endoplasmic system in vivo. This may be advantageous for fluoromicas that escape from medical implants or other devices where clearance is desirable, but suggests they would be of limited use in drug delivery or tissue targeting in vivo.
